IPO Boutique

Surface Oncology, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Surface Oncology, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Surface Oncology, Inc.SURF -
NASDAQ
$13.00-$15.00 $15.00 $14.757.2 million4/19/2018
Goldman Sachs, Cowen, Evercore ISI
Co-Manager(s):
Health Care
Filing(s):

Filed 2018-03-23
Terms Added 2018-04-09
Final Prospectus 2018-04-20



Surface Oncology, Inc. Quote & Chart - Click for current quote - SURF

About Surface Oncology, Inc. (adapted from Surface Oncology, Inc. prospectus):
They are a clinical-stage immuno-oncology company focused on using our specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment, or the TME, for the development of next-generation cancer therapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "SURF" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved